These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 16093267)

  • 1. Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial.
    Malkin CJ; Pugh PJ; West JN; van Beek EJ; Jones TH; Channer KS
    Eur Heart J; 2006 Jan; 27(1):57-64. PubMed ID: 16093267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
    Okun MS; Fernandez HH; Rodriguez RL; Romrell J; Suelter M; Munson S; Louis ED; Mulligan T; Foster PS; Shenal BV; Armaghani SJ; Jacobson C; Wu S; Crucian G
    Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study.
    Iellamo F; Volterrani M; Caminiti G; Karam R; Massaro R; Fini M; Collins P; Rosano GM
    J Am Coll Cardiol; 2010 Oct; 56(16):1310-6. PubMed ID: 20888520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart failure therapy: testosterone replacement and its implications.
    Rauchhaus M; Doehner W; Anker SD
    Eur Heart J; 2006 Jan; 27(1):10-2. PubMed ID: 16291772
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The perindopril in elderly people with chronic heart failure (PEP-CHF) study.
    Cleland JG; Tendera M; Adamus J; Freemantle N; Polonski L; Taylor J;
    Eur Heart J; 2006 Oct; 27(19):2338-45. PubMed ID: 16963472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism.
    Merza Z; Blumsohn A; Mah PM; Meads DM; McKenna SP; Wylie K; Eastell R; Wu F; Ross RJ
    Int J Androl; 2006 Jun; 29(3):381-91. PubMed ID: 16390499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of testosterone and nandrolone on cardiac function: a randomized, placebo-controlled study.
    Chung T; Kelleher S; Liu PY; Conway AJ; Kritharides L; Handelsman DJ
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):235-45. PubMed ID: 17223994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of testosterone replacement in middle-aged men with dysthymia: a randomized, placebo-controlled clinical trial.
    Seidman SN; Orr G; Raviv G; Levi R; Roose SP; Kravitz E; Amiaz R; Weiser M
    J Clin Psychopharmacol; 2009 Jun; 29(3):216-21. PubMed ID: 19440073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone supplementation in heart failure: a meta-analysis.
    Toma M; McAlister FA; Coglianese EE; Vidi V; Vasaiwala S; Bakal JA; Armstrong PW; Ezekowitz JA
    Circ Heart Fail; 2012 May; 5(3):315-21. PubMed ID: 22511747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nonspecific anti-inflammatory therapy with methotrexate for patients with chronic heart failure.
    Gong K; Zhang Z; Sun X; Zhang X; Li A; Yan J; Luo Q; Gao Y; Feng Y
    Am Heart J; 2006 Jan; 151(1):62-8. PubMed ID: 16368293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
    Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of physical training on exercise capacity, gas exchange and N-terminal pro-brain natriuretic peptide levels in patients with chronic heart failure.
    Maria Sarullo F; Gristina T; Brusca I; Milia S; Raimondi R; Sajeva M; Maria La Chiusa S; Serio G; Paterna S; Di Pasquale P; Castello A
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):812-7. PubMed ID: 17001223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial.
    Behling A; Rohde LE; Colombo FC; Goldraich LA; Stein R; Clausell N
    J Card Fail; 2008 Apr; 14(3):189-97. PubMed ID: 18381181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
    J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of METhotrexate therapy on the physical capacity of patients with ISchemic heart failure: a randomized double-blind, placebo-controlled trial (METIS trial).
    Moreira DM; Vieira JL; Gottschall CA
    J Card Fail; 2009 Dec; 15(10):828-34. PubMed ID: 19944358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life.
    Malkin CJ; Pugh PJ; Morris PD; Kerry KE; Jones RD; Jones TH; Channer KS
    Heart; 2004 Aug; 90(8):871-6. PubMed ID: 15253956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure.
    Krum H; Ashton E; Reid C; Kalff V; Rogers J; Amarena J; Singh B; Tonkin A
    J Card Fail; 2007 Feb; 13(1):1-7. PubMed ID: 17338996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.